The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort study
Abstract Background Vancomycin is a commonly used antibiotic in critically ill patients for various indications. Critical illness imposes pharmacokinetic-pharmacodynamics challenges, which makes optimizing vancomycin in this population cumbersome. Data are scarce on the clinical impact of time to th...
Guardado en:
Autores principales: | Khalid Al Sulaiman, Abdulrahman Alshaya, Ohoud Aljuhani, Amjad Alsaeed, Nadiyah Alshehri, Ramesh Vishwakarma, Hamdan Alzahrani, Sara Althewaibi, Nawaf Alghamdi, Khalid Alhelal, Aisha Alharbi, Shmeylan Al Harbi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c302358cd79b435f8eb8155df1f5a136 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Vancomycin in ICU Patients with Gram-Positive Infections: Initial Trough Levels and Mortality
por: Alshehri N, et al.
Publicado: (2020) -
Outcomes and Nephrotoxicity Associated with Vancomycin Treatment in Patients 80 Years and Older
por: Wang Y, et al.
Publicado: (2021) -
Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion
por: Christoph Tiede, et al.
Publicado: (2021) -
Diagnostic Value of Multiple Serum Biomarkers for Vancomycin-Induced Kidney Injury
por: Sang-Mi Kim, et al.
Publicado: (2021) -
<i>Clostridioides difficile</i> and Vancomycin-Resistant Enterococci in COVID-19 Patients with Severe Pneumonia
por: Kateřina Bogdanová, et al.
Publicado: (2021)